A SELECTIVE USE OF TISSUE-PLASMINOGEN ACTIVATOR AND STREPTOKINASE FORACUTE MYOCARDIAL-INFARCTION IS MORE COST-EFFECTIVE THAN THE EXCLUSIVEUSE OF TISSUE-PLASMINOGEN ACTIVATOR
R. Lorenzoni et al., A SELECTIVE USE OF TISSUE-PLASMINOGEN ACTIVATOR AND STREPTOKINASE FORACUTE MYOCARDIAL-INFARCTION IS MORE COST-EFFECTIVE THAN THE EXCLUSIVEUSE OF TISSUE-PLASMINOGEN ACTIVATOR, Journal of the American College of Cardiology, 29(2), 1997, pp. 79110-79110